2[2]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing: MIC testing supplemental tables[M].M100-S313(M7).2003.28-48.
3[3]Song JH.Global crisis of Streptococcus pneumoniae resistance; alarm calls from the east[A].3rd International Symposium on Antimicrobial Agent and Resistance,South Korea.ARFID,2001.53-67.
4[5]IPM,Lyond,Yung RWH,et al.Macrollide resistance in Stre-ptococcus pneumoniae in Hong Kong[J].Antimicrob Agents Chemother,2000,45(4): 1578-1581.
5[6]Amsden G,Amankwak.Pneumococal resistance: the treatme-nt challenge[J].Ann Pharmacother,2001,35(2): 480-486.
6[7]De Andrade,Brandileone MC,DiFabio SL,et al.Haemophi-lus influenzae resistance in Latin America: systematic review of surveillance data[J].Microb Drug Resist,2001,7(2): 403-411.
7[8]Blondeau JM,Tillotson GS.Antimicrobial susceptibility patterns of respiratory pathogens.A global perspective[J].Semin Respir Infect,2000,15: 195-207.
8Wald ER. Microbiology of acute and chronic sinusitis. Immunol Allergy Clin North Am.1994; 14:31-45.
9Kohler W, Schenk P. Cephalosporin treatment of maxillary sinusitis. Laryngorhinootologie. 1995; 74:355-360.
10Sydnor A Jr, Gwaltney JM Jr, Cocchetto DM, et al. Comparative evaluation of cefuroxime axetil and cefaclor for treament of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg.1989; 115:1430-1433.
